Awardee OrganizationRUSH UNIVERSITY MEDICAL CENTER
Description
Abstract Text
There is an increasing recognition that, in the long term, total joint
replacement (TJR) may be associated with adverse local and remote tissue
responses that are mediated by the degradation products of prosthetic
materials. There has been particular interest in the metallic
degradation products of THR because of the known toxicities of the
metallic elements that comprise the implant alloys. In this long term
study, we have been investigating metal release, transport, storage and
excretion in patients with total hip and knee replacements. In the
current grant period, we have demonstrated that (1) elevations in serum
titanium and chromium can be detected in individuals with well
functioning total hip and knee replacements; (2) the highest chromium
and cobalt levels have been observed in patients with metal-on-metal
bearings; (3) passive dissolution from extensively porous coated cobalt-
base alloy femoral stems is not a dominant model of metal release;
rather, fretting corrosion of femoral components at modular junctions is
more closely associated with elevations in serum chromium; (4) cobalt-
and titanium-alloy particulate degradation products from TJR commonly
disseminate to paraaortic lymph nodes, liver and spleen, particularly in
individuals who have had a failed TJR; and (5) there are indications
that individuals with elevated serum metal content may have associated
liver cell injury.
We propose to expand on these studies to (1) quantify metal release in
the prospective study group which will be 7 to 12 years postoperative,
an interval in which complications related to the implant are more
prevalent; (2) prospectively follow patients up to 8 years after
revision surgery who have demonstrated significant elevations in serum
metal content to determine if serum metal transport diminishes with
time; (3) expand our autopsy retrieval program to characterize not only
tissue metal levels and systemic distribution of particulate wear debris
but also the tissue and cellular localization of these degradation
products; and (4) conduct bioavailability and bioreactivity studies of
circulating metal-protein complexes which result from corrosion and wear
of joint replacement components.
This is one of four grants in an Orthopaedic Biomaterials Investigator-
Initiated Interactive Research Project Grant entitled "Safety and
Efficacy of Permanent Skeletal Replacement Implants". The studies
proposed here address safety issues and are deemed critical in order to
understand the prospective risks to patients undergoing total joint
arthroplasty.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
X rayaluminum oxideatomic absorption spectrometrybiological transportbiomaterial compatibilitybiomaterial evaluationblood chemistrychromiumcobaltcorrosionship prosthesishuman subjectjoint prosthesiskneelongitudinal human studymanganesemedical implant sciencemetal poisoningnanotechnologynickelorthopedicspostoperative complicationsscanning electron microscopytitaniumurinalysisvanadium
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
068610245
UEI
C155UU2TXCP3
Project Start Date
01-May-1989
Project End Date
31-December-2003
Budget Start Date
01-June-2001
Budget End Date
31-December-2001
Project Funding Information for 2001
Total Funding
$8,024
Direct Costs
$5,559
Indirect Costs
$2,465
Year
Funding IC
FY Total Cost by IC
2001
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$8,024
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3R01AR039310-11S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01AR039310-11S1
Patents
No Patents information available for 3R01AR039310-11S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01AR039310-11S1
Clinical Studies
No Clinical Studies information available for 3R01AR039310-11S1
News and More
Related News Releases
No news release information available for 3R01AR039310-11S1
History
No Historical information available for 3R01AR039310-11S1
Similar Projects
No Similar Projects information available for 3R01AR039310-11S1